Vimarsana
Biggest News Aggregation in the World

Mohamed Eid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mohamed Eid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mohamed Eid Today - Breaking & Trending Today

Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack -April 06, 2024 at 09:54 am EDT - Vimarsana News

Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack -April 06, 2024 at 09:54 am EDT

Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® on risk of heart failure hospitalization and death in adults following a...

Assad arrest warrant: 'Hope and pain' for Syrian chemical attack survivors | Syria's War - Vimarsana News

Assad arrest warrant: 'Hope and pain' for Syrian chemical attack survivors | Syria's War

Lawyers say French arrest warrant sets ‘historic precedent’ as survivors of chemical massacre long for justice in Syria.

Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study - Vimarsana News

Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study

Boehringer Ingelheim and Carelon Research have conducted the first large-scale U.S. validation of a new AI-driven tool for chronic kidney disease (CKD) The Klinrisk model predicted disease progression in over 80% of individuals at all stages of the disease, based on data from a diverse population of over 4 million U.S. adults Validated tools to […]

Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study - Vimarsana News

Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study

/PRNewswire/ -- Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a machine-learning tool developed to predict...

Lilly - Hip-Hop Classic 'It Takes Two' Takes on New Meaning in Remix to Elevate Importance of Testing for Kidney Disease - Vimarsana News

Lilly - Hip-Hop Classic 'It Takes Two' Takes on New Meaning in Remix to Elevate Importance of Testing for Kidney Disease

RIDGEFIELD - More than 35 million adults in the U.S. have chronic kidney disease . However, as many as 90% of them are unaware of their condition. This is despite clinical guidelines, which show that...